Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Life Sciences Industry Analysis

UpdatedNov 25, 2025
DataAggregated Company Financials
Companies9
  • 7D3.1%
  • 3M1.3%
  • 1Y16.4%
  • YTD10.2%

Over the last 7 days, the Life Sciences industry has risen 4.7%, driven by gains from AddLife of 5.6%. During this same period, the Promimic underperformed, falling 7.1%. This takes the industry's 12 month performance to a gain of 17%. Looking forward, earnings are forecast to grow by 27% annually.

Industry Valuation and Performance

Has the Swedish Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 01 Dec 2025SEK 33.8bSEK 14.9b-SEK 744,515,427.0056.5x-45.5x2.3x
Wed, 29 Oct 2025SEK 38.3bSEK 14.8bSEK 117.3m56.1x326.4x2.6x
Fri, 26 Sep 2025SEK 34.0bSEK 14.7bSEK 61.3m56.4x555x2.3x
Sun, 24 Aug 2025SEK 35.4bSEK 14.7bSEK 59.9m58.8x591.4x2.4x
Tue, 22 Jul 2025SEK 46.1bSEK 16.7bSEK 444.3m62.1x103.8x2.8x
Thu, 19 Jun 2025SEK 46.5bSEK 16.6bSEK 405.8m71.1x114.7x2.8x
Sat, 17 May 2025SEK 46.4bSEK 16.6bSEK 415.3m45x111.7x2.8x
Mon, 14 Apr 2025SEK 34.9bSEK 16.6bSEK 609.4m36.9x57.3x2.1x
Wed, 12 Mar 2025SEK 36.4bSEK 16.6bSEK 614.9m39.2x59.2x2.2x
Fri, 07 Feb 2025SEK 44.1bSEK 17.0b-SEK 1,038,511,426.0044x-42.4x2.6x
Sun, 05 Jan 2025SEK 43.5bSEK 16.7b-SEK 1,152,911,426.0049.2x-37.8x2.6x
Tue, 03 Dec 2024SEK 42.4bSEK 16.7b-SEK 1,154,323,426.0049x-36.7x2.5x
Thu, 31 Oct 2024SEK 43.8bSEK 16.8b-SEK 956,465,491.0051.1x-45.8x2.6x
Sat, 28 Sep 2024SEK 48.3bSEK 16.7b-SEK 988,175,491.0059.2x-48.9x2.9x
Mon, 26 Aug 2024SEK 48.7bSEK 16.7b-SEK 986,068,538.0061.2x-49.4x2.9x
Wed, 24 Jul 2024SEK 49.2bSEK 16.6b-SEK 1,138,220,510.0059.8x-43.3x3x
Fri, 21 Jun 2024SEK 42.6bSEK 16.3b-SEK 1,188,686,510.0055x-35.9x2.6x
Sun, 19 May 2024SEK 42.2bSEK 16.3b-SEK 1,188,457,671.0060.7x-35.5x2.6x
Tue, 16 Apr 2024SEK 38.3bSEK 16.0b-SEK 1,122,792,213.0035.3x-34.1x2.4x
Thu, 14 Mar 2024SEK 40.4bSEK 16.0b-SEK 1,123,139,210.0042x-35.9x2.5x
Sat, 10 Feb 2024SEK 39.7bSEK 15.8b-SEK 1,473,823,683.0056.5x-26.9x2.5x
Mon, 08 Jan 2024SEK 35.9bSEK 15.5b-SEK 1,393,723,683.0043.5x-25.8x2.3x
Wed, 06 Dec 2023SEK 35.2bSEK 15.5b-SEK 1,393,723,683.0042.2x-25.3x2.3x
Fri, 03 Nov 2023SEK 31.0bSEK 15.4b-SEK 1,255,923,711.0034.1x-24.7x2x
Sun, 01 Oct 2023SEK 26.8bSEK 15.1b-SEK 1,134,516,711.0039.8x-23.6x1.8x
Tue, 29 Aug 2023SEK 30.6bSEK 15.1b-SEK 1,138,067,831.0041x-26.9x2x
Thu, 27 Jul 2023SEK 33.0bSEK 14.9b-SEK 239,671,038.0047.5x-137.6x2.2x
Sat, 24 Jun 2023SEK 35.7bSEK 14.6b-SEK 172,476,038.0038.7x-207.1x2.4x
Mon, 22 May 2023SEK 39.6bSEK 14.6b-SEK 175,477,906.0040.1x-225.6x2.7x
Wed, 19 Apr 2023SEK 32.5bSEK 14.6b-SEK 57,449,459.0034.1x-566x2.2x
Fri, 17 Mar 2023SEK 34.1bSEK 14.6b-SEK 57,185,459.0031.9x-596.2x2.3x
Sun, 12 Feb 2023SEK 40.4bSEK 14.4bSEK 827.0m37.3x48.9x2.8x
Tue, 10 Jan 2023SEK 39.7bSEK 14.2bSEK 943.9m40.5x42.1x2.8x
Thu, 08 Dec 2022SEK 37.1bSEK 14.1bSEK 944.3m41.9x39.3x2.6x
Price to Earnings Ratio

39.3x


Total Market Cap: SEK 37.1bTotal Earnings: SEK 944.3mTotal Revenue: SEK 14.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Life Sciences Industry Price to Earnings3Y Average -15.4x202320242025
Current Industry PE
  • Investors are relatively neutral on the Swedish Life Sciences industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 2.5x.
Past Earnings Growth
  • Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market2.28%
Healthcare2.43%
Life Sciences3.07%
Clinical Research and Equipment3.07%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALIF B AddLifeSEK 189.003.4%
+SEK 767.7m		40.7%PE58.5x
BICO BICO GroupSEK 21.1816.4%
+SEK 210.3m		-34.1%PS0.8x
MCAP MedCapSEK 549.000.9%
+SEK 74.9m		-1.6%PE41.8x
GENO Genovis AB (publ.)SEK 20.201.4%
+SEK 18.5m		-19.5%PE63x
LEVBIO Level BioSEK 0.3513.6%
+SEK 2.9m		10.8%PS0.8x

Latest News

ALIF B
SEK 189.00
AddLife
7D
3.4%
1Y
40.7%

ALIF B: Stable Financial Metrics Will Support Future Upward Momentum

Analysts have maintained their price target for AddLife at SEK 213.50, citing ongoing stable forecasts for the company's key financial metrics and reaffirming their confidence in its market position. Valuation Changes Consensus Analyst Price Target remains unchanged at SEK 213.50.
MAGLE
SEK 17.80
Magle Chemoswed Holding
7D
-1.7%
1Y
-44.4%

Sentiment Still Eluding Magle Chemoswed Holding AB (publ) (STO:MAGLE)

Nov 21
Sentiment Still Eluding Magle Chemoswed Holding AB (publ) (STO:MAGLE)
PRO
SEK 15.80
Promimic
7D
-7.3%
1Y
-41.3%
GENO
SEK 20.20
Genovis AB (publ.)
7D
1.4%
1Y
-19.5%

Genovis AB (publ.)'s (STO:GENO) Weak Earnings May Only Reveal A Part Of The Whole Picture

Nov 15
Genovis AB (publ.)'s (STO:GENO) Weak Earnings May Only Reveal A Part Of The Whole Picture
IDLDX
SEK 0.41
IDL Diagnostics
7D
-2.9%
1Y
7.4%
BICO
SEK 21.18
BICO Group
7D
16.4%
1Y
-34.1%
MCAP
SEK 549.00
MedCap
7D
0.9%
1Y
-1.6%

Earnings Troubles May Signal Larger Issues for MedCap (STO:MCAP) Shareholders

Nov 06
Earnings Troubles May Signal Larger Issues for MedCap (STO:MCAP) Shareholders
PEXA B
SEK 0.23
PExA
7D
-1.7%
1Y
-40.4%
ATANA
SEK 0.01
Attana
7D
11.1%
1Y
-58.3%
LEVBIO
SEK 0.35
Level Bio
7D
13.6%
1Y
10.8%